Compare AVPT & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVPT | STAA |
|---|---|---|
| Founded | 2001 | 1982 |
| Country | United States | United States |
| Employees | 3443 | N/A |
| Industry | Computer Software: Prepackaged Software | Ophthalmic Goods |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.1B |
| IPO Year | N/A | 1995 |
| Metric | AVPT | STAA |
|---|---|---|
| Price | $13.57 | $22.66 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 9 |
| Target Price | $16.64 | ★ $22.81 |
| AVG Volume (30 Days) | ★ 1.3M | 786.9K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | N/A | ★ $239,442,000.00 |
| Revenue This Year | $25.00 | $30.82 |
| Revenue Next Year | $19.63 | $8.41 |
| P/E Ratio | $1,348.94 | ★ $87.15 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.84 | $15.59 |
| 52 Week High | $16.06 | $35.87 |
| Indicator | AVPT | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 55.47 | 45.10 |
| Support Level | $12.92 | $21.72 |
| Resistance Level | $13.98 | $24.31 |
| Average True Range (ATR) | 0.45 | 0.93 |
| MACD | -0.09 | 0.09 |
| Stochastic Oscillator | 55.77 | 50.10 |
AvePoint Inc is a provider of modern data protection, enabling organizations to secure, govern, and operationalize data at scale across cloud ecosystems. Customers rely on the AvePoint Confidence Platform to reduce risk, improve operational efficiency, and accelerate digital transformation as it adopt cloud collaboration and artificial intelligence (AI)-driven developed tools and workflows. Its products and services are sold throughout the world, through direct and indirect sales channels.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.